1. Home
  2. TRDA vs FRPH Comparison

TRDA vs FRPH Comparison

Compare TRDA & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • FRPH
  • Stock Information
  • Founded
  • TRDA 2016
  • FRPH 1986
  • Country
  • TRDA United States
  • FRPH United States
  • Employees
  • TRDA N/A
  • FRPH N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • FRPH Real Estate
  • Sector
  • TRDA Health Care
  • FRPH Finance
  • Exchange
  • TRDA Nasdaq
  • FRPH Nasdaq
  • Market Cap
  • TRDA 609.7M
  • FRPH 555.7M
  • IPO Year
  • TRDA 2021
  • FRPH N/A
  • Fundamental
  • Price
  • TRDA $17.85
  • FRPH $31.17
  • Analyst Decision
  • TRDA Strong Buy
  • FRPH
  • Analyst Count
  • TRDA 3
  • FRPH 0
  • Target Price
  • TRDA $23.33
  • FRPH N/A
  • AVG Volume (30 Days)
  • TRDA 132.5K
  • FRPH 21.8K
  • Earning Date
  • TRDA 11-05-2024
  • FRPH 11-06-2024
  • Dividend Yield
  • TRDA N/A
  • FRPH N/A
  • EPS Growth
  • TRDA N/A
  • FRPH 45.62
  • EPS
  • TRDA 1.55
  • FRPH 0.40
  • Revenue
  • TRDA $215,232,000.00
  • FRPH $31,414,000.00
  • Revenue This Year
  • TRDA $47.63
  • FRPH N/A
  • Revenue Next Year
  • TRDA N/A
  • FRPH N/A
  • P/E Ratio
  • TRDA $11.51
  • FRPH $77.94
  • Revenue Growth
  • TRDA 146.92
  • FRPH 4.04
  • 52 Week Low
  • TRDA $10.75
  • FRPH $26.99
  • 52 Week High
  • TRDA $20.49
  • FRPH $32.50
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 48.42
  • FRPH 61.75
  • Support Level
  • TRDA $19.28
  • FRPH $30.45
  • Resistance Level
  • TRDA $20.49
  • FRPH $31.70
  • Average True Range (ATR)
  • TRDA 0.92
  • FRPH 0.62
  • MACD
  • TRDA -0.01
  • FRPH 0.12
  • Stochastic Oscillator
  • TRDA 25.21
  • FRPH 82.33

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

About FRPH FRP Holdings Inc.

FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).

Share on Social Networks: